Pharma Readies For Price Caps On Glargine, Teneligliptin, Lenalidomide In India

Ranitidine Among 26 Drugs Dropped From NLEM 2022

India’s national list of essential medicines 2022 features 34 additions, including insulin glargine, teneligliptin, lenalidomide, bedaquiline and montelukast, with price control expected to follow on these drugs.

Price Controls Expected For Several New Drugs In India • Source: Shutterstock

Seven years after the last revision in 2015, India has announced its latest national list of essential medicines (NLEM), which covers 384 drugs in total across 27 therapeutic categories and adds 34 therapies, including insulin glargine, teneligliptin, lenalidomide and montelukast, to the roster.

While the primary objective of the NLEM is to promote the rational use of drugs with an eye on cost,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from India

More from Asia